Drs. Woods (Tulane Physiology) and Khismatullin have received a R01 grant from the National Heart, Lung, and Blood Institute of the NIH to investigage the molecular mechanisms of endothelial dysfunction and atherosclerotic plaque development in patients with diabetes. Dr. Khismatullin's role in this project is to study endothelial dysfunction and monocyte-endothelium adhesion caused by mediators present in microparticles released from diabetic smooth muscle cells. This study involves experiments with the Bioflux 200 microfluidic shear flow system installed in Dr. Khismatullin's lab.
